Skip to content

Analysis of Risk Factors and Resistance Genes for Carbapenem-Resistant Acinetobacter baumannii Bloodstream Infections: A Retrospective Study.

Jul 2026 · Microbial Drug Resistance · pp. 10766294261467800 · 0 citations · 29 references
Medicine

TL;DR

Inappropriate empirical antimicrobial therapy, deep venous catheterization, prolonged hospitalization before the onset of BSIs and ICU admission are independent risk factors for CRAb BSIs.

Abstract

Objective

The prevalence of carbapenem-resistant Acinetobacter baumannii (CRAb) has been increasing globally. This study aimed to investigate the risk factors, resistance gene profiles, and molecular epidemiology of CRAb bloodstream infections (BSIs) among patients in Xi'an, China, to provide evidence for clinical prevention and targeted treatment.

Methods

We conducted a retrospective study of 139 patients with A. baumannii BSIs. Patients were categorized into a CRAb group (n = 84) and a carbapenem-susceptible A. baumannii (CSAb) group (n = 55). Independent risk factors were identified via multivariate logistic regression analysis. Carbapenemase resistance genes were detected using polymerase chain reaction (PCR), and CRAb isolates were molecularly typed by multilocus sequence typing (MLST).

Results

Multivariate logistic regression analysis identified the following as independent risk factors for CRAb BSIs: inappropriate empirical antimicrobial therapy (OR = 8.620; 95% CI: 2.078-35.751), deep venous catheterization (OR = 12.625; 95% CI: 2.263-70.429), prolonged hospitalization before the onset of BSIs (OR = 1.467; 95% CI: 1.123-1.915), and ICU admission (OR = 4.981; 95% CI: 1.898-13.065). Antimicrobial susceptibility testing showed that CRAb isolates were multidrug-resistant, exhibiting resistance rates exceeding 70% to most common clinical antibiotics, with the exception of tigecycline (5.95% resistance) and colistin (27.38% resistance). All 84 CRAb isolates carried both blaOXA-51-like and blaOXA-23-like genes, while other carbapenemase genes were not detected. MLST identified 7 sequence types (STs), with ST540 (45.24%, 38/84) being the dominant clone. eBURST analysis indicated that the major STs (ST195, ST208, etc.) belonged to the same clonal complex.

Conclusion

Inappropriate empirical antimicrobial therapy, deep venous catheterization, prolonged hospitalization before the onset of BSIs and ICU admission are independent risk factors for CRAb BSIs. The prevalent strains produce OXA-23-like carbapenemase, and molecular typing indicates that the ST540 clone and its related clonal complex are predominant, suggesting potential nosocomial clonal spread.

View source

Similar papers

Open access Sep 2026

Demographic, Clinical, and Antibiotic Exposure Factors Associated with Carbapenem-Resistant Acinetobacter baumannii: An Eight-Year Retrospective Study

These findings support strengthening antimicrobial stewardship, particularly the appropriate use and continuous evaluation of carbapenem therapy, alongside enhanced surveillance and infection prevention measures among high-risk patients.

Angky Budianti, Dzaki Fadlurrahman Ayyasy, Mubarokah Mubarokah et al. · 0 citations
Open access Aug 2026

International high-risk clones of Acinetobacter baumannii in Genbank: analysis of 47 738 whole-genome sequences

Introduction. Acinetobacter baumannii is a major cause of hospital-acquired infections and is frequently associated with multidrug resistance, particularly among international clones of high risk (ICs), whose identification within the hospital is important for risk assessment. Since our previous analysis of the Genbank...

A. Shelenkov, A. Slavokhotova, Yu. D. Mikhaylova et al. · 1 citation
Review Open access Aug 2026

Prevalence, mortality, risk factors, and treatment of carbapenem-resistant hypervirulent Klebsiella pneumoniae: an evidence map.

PURPOSE Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKP) is a critical global health threat due to its hypervirulence and multidrug resistance, causing severe, high-mortality infections. This study systematically reviews its epidemiology, risk factors, treatment strategies, and activity. METHODS We...

Xiaoyu Chai, Qianyi Zhou, Wei Jiang et al. · 0 citations
Sep 2026

Risk Factors for Extended-Spectrum β-lactamase, Carbapenem, and Colistin Resistance Among Enterobacterales Bloodstream Infections in Intensive Care Units.

Enterobacterales bloodstream infections (E-BSIs) in intensive care units (ICUs) are increasingly complicated by antimicrobial resistance. This retrospective study evaluated resistance patterns and phenotype-specific risk factors for extended-spectrum β-lactamase (ESBL) production and carbapenem and colistin resistance...

Fahriye Melis Gürsoy Kurtoğlu, A. Altunsoy, Sümeyye Nur Aydın et al. · 0 citations
Sep 2026

Investigation of carbapenemase gene distribution in Acinetobacter baumannii in a region with high carbapenem resistance and detection of a silent NDM outbreak.

Carbapenem resistance driven by carbapenemase production in Gram-negative bacteria is a global threat. Carbapenem-resistant Acinetobacter baumannii (CRAb) is a critical priority pathogen listed by the World Health Organization (WHO). While blaOXA-23 and blaOXA-24/40-like are most frequently reported in CRAb, an increas...

Hanife Tutan, Bilge Mazlumoğlu, Leyla Genç et al. · 0 citations
Open access Sep 2026

Risk factors associated with carbapenem-resistant Gram-negative bacterial infections in intensive care units in Jordan

Carbapenem-resistant Gram-negative bacteria (CR-GNB) pose major challenges in intensive care units (ICUs) due to limited treatment options and high mortality. Data describing their predictors in Jordan are scarce. This study aimed to identify risk factors associated with CR-GNB infections among ICU patients. A retrospe...

Mohammad Gharaibeh, O. Sayyouh, M. El-Shokry et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.